Orally administered drugs susceptible to calcium chelation

Orally administered drugs susceptible to calcium chelation represent a broad pharmacological category of medications that interact chemically with calcium ions (Ca2+) within the gastrointestinal tract (StatPearls: Drug-Food Interactions, 2023). These drugs typically contain functional groups, such as hydroxyl, carboxyl, or ketone groups in specific spatial arrangements, that allow them to act as ligands, forming stable and often insoluble coordination complexes with divalent cations (Journal of Pharmaceutical Sciences: Chelation of Drugs with Metal Ions). This chelation process significantly impairs the drug's ability to permeate the intestinal mucosa, leading to a marked reduction in systemic absorption and bioavailability (PubMed: PMC7073459). Clinical consequences of this interaction include sub-therapeutic drug levels, which can result in treatment failure for infections, inadequate management of chronic conditions like osteoporosis or hypothyroidism, and the potential emergence of drug resistance in the case of antibiotics or antivirals (FDA: Cipro Prescribing Information). To mitigate these effects, patients are generally advised to separate the administration of these medications from the consumption of dairy products, calcium supplements, or calcium-containing antacids by several hours.

Other names

Calcium-sensitive drugsChelatable oral medicationsCation-sensitive drugsMetal-binding drugs

Formation of non-absorbable, insoluble chelate complexes with calcium ions in the gastrointestinal lumen, which prevents the drug from crossing the intestinal epithelium and reduces systemic bioavailability (PubMed: PMC7073459).